Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-Lymphocyte Interactions with the Neurovascular Unit: Implications in Intracerebral Hemorrhage. | Cells | 2022 | 35805099 | PubTator, text mining | PubMed |
| Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer. | Medicine (Baltimore) | 2022 | 35801800 | PubTator, text mining | PubMed |
| TCF7 is highly expressed in immune cells on the atherosclerotic plaques, and regulating inflammatory signaling via NFκB/AKT/STAT1 signaling. | Biosci Rep | 2022 | 35792753 | PubTator, text mining | PubMed |
| Avidity in antibody effector functions and biotherapeutic drug design. | Nat Rev Drug Discov | 2022 | 35790857 | PubTator, text mining | PubMed |
| The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells. | Transplant Cell Ther | 2022 | 35788086 | PubTator, text mining | PubMed |
| CD137 Costimulation Enhances the Antitumor Activity of Vγ9Vδ2-T Cells in IL-10-Mediated Immunosuppressive Tumor Microenvironment. | Front Immunol | 2022 | 35784354 | PubTator, text mining | PubMed |
| Necroptosis-Related Genes Associated With Immune Activity and Prognosis of Colorectal Cancer. | Front Genet | 2022 | 35783272 | PubTator, text mining | PubMed |
| Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods. | Comput Math Methods Med | 2022 | 35774297 | PubTator, text mining | PubMed |
| Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies. | Hematol Oncol Clin North Am | 2022 | 35773048 | PubTator, text mining | PubMed |
| Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma. | Aging (Albany NY) | 2022 | 35771136 | PubTator, text mining | PubMed |
| Differential Contribution of NF-κB Signaling Pathways to CD4+ Memory T Cell Induced Activation of Endothelial Cells. | Front Immunol | 2022 | 35769477 | PubTator, text mining | PubMed |
| The Past, Present, and Future of Non-Viral CAR T Cells. | Front Immunol | 2022 | 35757746 | PubTator, text mining | PubMed |
| Role of Adenoviruses in Cancer Therapy. | Front Oncol | 2022 | 35756634 | PubTator, text mining | PubMed |
| Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. | Dis Markers | 2022 | 35756491 | PubTator, text mining | PubMed |
| Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy. | Front Immunol | 2022 | 35747139 | PubTator, text mining | PubMed |
| The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy. | Cells | 2022 | 35741080 | PubTator, text mining | PubMed |
| Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers. | Cancers (Basel) | 2022 | 35740539 | PubTator, text mining | PubMed |
| Narrative Review of Synergistics Effects of Combining Immunotherapy and Stereotactic Radiation Therapy. | Biomedicines | 2022 | 35740435 | PubTator, text mining | PubMed |
| Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma. | Front Immunol | 2022 | 35734169 | PubTator, text mining | PubMed |
| Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study. | Bioengineered | 2022 | 35726370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=45